Expanding SFC Applications at a Major Pharmaceutical Company

Library Number:
LITR134853801
Part Number:
720005382EN
Author(s):
Waters
Source:
Waters
Content Type:
Literature
Content Subtype:
Case Studies

This business case examines the benefits of deploying UltraPerformance Convergence Chromatography™ (UPC2®) as the analytical SFC technology at a major pharmaceutical organization. Its use of SFC has jumped from less than 20 percent of chiral samples to 80 percent, and from zero to 50 percent of achiral samples. Preliminary figures show the company has saved $150,000 in annual solvent costs, $20,000 in annual evaporation costs, and $25,000 in annual delivery time costs, while achieving improvements in quality, safety, and performance.


Title Format File Size
Download (720005382en) PDF 962.38kB